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measurable, nonreversible restriction in air flow, comorbidities contribute to the severity of the disease (Huertas and Palange, 2011) . In fact, research has suggested that depressive disorders or depression-like symptoms occur in between 40 % and 74 % of patients with COPD (Fabbri et al., 2004; Panagioti et al., 2014) . Therefore, COPD comorbidities should be frequently expected clinical problems, and the therapeutic strategy of COPD has moved from an emphasis on lung function recovery to the simultaneous treatment of its comorbidities (Blakemore et al., 2014a) . Major depressive disorder is a prevalent and severe COPD comorbid disorder that is often underdiagnosed and undertreated (Janssen et al., 2010) , and clinically relevant evidence is robust. For instance, depression scale scores exacerbated in patients with COPD (Magda, 2010) , and the mortality rate were much higher in COPD patients who suffered from symptoms of depression than those who did not (Halabi et al., 2011) . A recent meta-analysis showed a bidirectional association between COPD and depression, according to which COPD added to the risk of depression progression, and depression was also associated with worse outcomes in COPD (Blakemore et al., 2014b; Atlantis et al., 2013) .
The pathobiology of COPD with depression is far from clear. In addition, an appropriate animal model is essential to the research of the complex pathogenesis of the disorder. Cigarette smoking is a profound inflammatory stimulus that may induce excess production of proinflammatory cytokines and recruit macrophages, neutrophils, and lymphocytes to the lung tissue, which are primary factors associated with the development of COPD. In addition, studies have suggested that tobacco smoke exposure was associated with a deterioration of brain functions and a higher level of depressiveness (Bratek et al., 2015) . Inhibition of cytokines may be a therapeutic strategy for the treatment of COPD with comorbid depression. Previous studies suggested that the levels of a number of inflammatory biomarkers, including cytokines, played a crucial role in the aetiology of depression in COPD. Clinical studies showed that inflammatory cytokines, such as interleukin-6 (IL-6) and interleukin-1β (IL-1β), were higher in patients with clinically relevant symptoms of depression (Eagan et al., 2010) . Other reports have also suggested a relationship between tumour necrosis factor alpha (TNF-α) and depression scores in patients with COPD (Al-shair et al., 2011) . The inflammasome was hypothesized to be a key mediator of the response to physiological and psychological stressors, and its dysregulation might be implicated in COPD as well as in major depressive disorders (Wong et al., 2016; Grailer et al., 2014) . Inflammasome activation induces the maturation of caspase-1 and the activation of IL-1β and IL-18, which are two inflammatory cytokines involved in both lung injuries and neuroinflammation.
Previous studies showed that cytokine signalling in the brain was associated with the function of the hypothalamic-pituitary-adrenal (HPA) axis, synaptic plasticity, and the neuroendocrine system, all of which are known as important factors of the aetiopathogenesis of depression (Wang and Campbell, 2002) . HPA axis dysfunctions in depression were manifested as aberrant adrenal glucocorticoid (GC) secretion and abnormal hormone feedback loops (Nemeroff et al., 1984; Bardeleben and Wiedemann, 1987) . GC was long renowned for performing salient immunosuppressive and anti-inflammatory functions through various genomic and nongenomic mechanisms. These recognised actions of the steroid hormone have been widely applied clinically, and synthetic GC derivatives are commonly used for the therapy of COPD. However, the role of the HPA axis and GC in modulating immune responses is still unclear in light of accumulating evidence suggesting that GC acts as both permissive and stimulatory effects on the immune system under specific conditions. Such paradoxical actions of GC are particularly evident in the brain, where substantial data support either a beneficial or detrimental role of the steroid hormone. In the central nervous system (CNS), the neuroendocrine system acts through the activation of hormone receptors, including glucocorticoid receptor (GR), to exert powerful modulatory effects on immune responses (Beato et al., 1995) . GR could be activated by GC, and its inflammatory mediation actions were also very complex as well as context dependent in the brain (Goulding, 2004) . For instance, GR antagonist was shown to exacerbate cell injury initiated by lipopolysaccharide injection, indicating a robust protective function of GR (Bellavance and Rivest, 2014) .
An increased GC level responding to psychogenic stressors, including unpredictable stress, restraint stress, or social defeat, was correlated with the release of inflammatory cytokines. Meanwhile, HPA axis dysfunction during aging led to chronical GC elevation, which was considered to contribute to the immunosenescence exemplified by a sustained low release of inflammatory molecules (Panda et al., 2009; Njie et al., 2012) . From the above context, GC-GR appears to exert either pro-or anti-inflammatory actions, and what its exact action is during depression in COPD has not been clarified.
How GR mediates the biological actions of corticosteroids and the integrity of GR signalling is crucial for an effective GC action (Beato et al., 1995) . Upon binding to ligands, GR translocates into the nucleus and interacts with GC response elements in the promoter region of corticosteroid-target genes, which induces transcription. As a phosphoprotein, GR can be phosphorylated on multiple sites (Bodwell et al., 1991) .
Once the ligand-free receptor is phosphorylated, additional phosphorylation events occur in conjunction with ligand bindings (Ismaili and Garabedian, 2004) . GR sites, serine 211 (S211) and serine 226 (S226) in human, corresponding to serine (S232) and serine (S246) in rats, cluster to the N-terminal transcriptional regulatory domain.
In contrast, phosphorylation of S226 by c-Jun N-terminal kinase inhibits GR transcriptional activation (Rogatsky et al., 1998) . GR nucleus translocation is both essential and necessary for corticosteroid actions. Whether the effects of the HPA axis and inflammasome activation are regulated through GR-regulated pathways and whether there is a common mechanism underlying the cross talk between lung and brain need to be further clarified. In the present study, we characterised the molecular mechanism underlying the GC-GR action in mediating inflammation through an in vivo COPD-induced mice model of depression, which might help to explain the high comorbidity between depression and COPD.
Materials and methods

Animals.
Male C57 BL/6J mice were purchased from the Shanghai Jie Sijie Experimental Animal Co. Ltd. (Shanghai, China) and housed under a 12:12 h light-dark cycle, with a constant temperature of 22 to 24 °C and relative humidity (50-60%). They were fed with free access to food and water and allowed 1 weeks of acclimatization to the laboratory environment. All experiments were performed strictly in accordance with the Provision and General Recommendation of Chinese Experimental Animals Administration Legislation and Medicine Animal Care and Use Committee of China Pharmaceutical University.
Cigarette smoke-stimulated procedure and experimental design.
The male C57 BL/6J mice were exposed to either the whole cigarette smoke (CS) or room air in a smoking device for 16 consecutive weeks. The CS was produced by burning commercial filter-tipped cigarettes containing 10 mg tar and 1.0 mg nicotine per cigarette. Animals were exposed to the smoke twice a day for 30 min each time, with 5 cigarettes per time. The non-CS groups were exposed to fresh air. Animals were divided into four groups randomly: non-CS + vehicle (VEH) group, non-CS + fluoxetine (FLU, 10 mg/kg) group, CS + VEH group, and CS + FLU (10 mg/kg) group, which had the average sucrose intake ranges. The mice were treated with FLU (10 mg/kg, Changzhou Siyao Pharmaceuticals Co., Ltd, Changzhou, China) or saline (VEH) 1 h before exposure to fresh air or CS once a day by oral gavage. The diagrammatic representation of the experimental CS procedure is presented in Fig. 1A .
Behavioural tests were determined 24 h after the last CS exposure. After the behavioural tests, blood samples were collected from the retro-orbital plexus. The animals were then sacrificed, and the bronchoalveolar lavage fluid (BALF) and brain tissues were collected for further study.
Body weight and sucrose intake test.
Body weight was measured every week during the experiment paradigm. Sucrose preference (SP) tests have been well-recognised as reflecting anhedonia-like behaviour, which was defined as a core symptom of depression in depressive rodent models (Willner, 1997) . Here, we measured the sucrose consumption of animals every 2 weeks to record the depressive state of CS-stimulated mice. The experimental protocol was as follows: sucrose intake was determined by a 12 h period of food and water deprivation followed by offering a free choice between 1 % sucrose solution and tap water for 12 h. To prevent possible effects of side preference in drinking behaviours, the positions of the bottles of sucrose solution and the tap water were switched after 6 h. The consumptions of the sucrose solution and water were weighed, and the SP was calculated as a percentage of the consumed sucrose solution relative to the total amount of liquid consumed. SP was calculated with the following formula: SP = sucrose intake/(sucrose intake + water intake) × 100 %. Subsequently, the sucrose solution intake test was monitored under similar conditions at 2-week intervals for the entire CS-stimulated procedure. Animals with extraordinary variations in sucrose intake on the final baseline test were discarded, and remaining animals, which had an average intake range, were randomly divided into the indicated groups.
Open field test.
The open field test was adopted to determine the locomotor activity of animals. In the open field paradigm, mice were subjected to the open field apparatus, which was divided into symmetrical sectors. At the beginning, mice were placed in the centre of the apparatus. Each mouse was permitted to explore freely for 6 min. The numbers of crossing, rearing and grooming in the last 4 min were counted by a trained observer, who was blinded to the experimental group.
Tail suspension test and forced swimming test.
The tail suspension test (TST) was performed as previously described (Steru et al., 1985) . In this experiment, mice were acoustically and visually isolated in a quiet environment. Mice were individually suspended by placing adhesive tape on their tails (about 50 cm above the floor). Each mouse was suspended for a period of 6 min.
The time of immobility was recorded during the last 4 min. The forced swimming test (FST) was performed as previously described (Deng et al., 2015) . In brief, mice were individually subjected to a Plexiglas cylinder (25 cm in height and 20 cm in diameter) filled with 25 ± 2 °C water, the depth of which ensured that the mice could not touch the bottom with their tails. The immobility time was recorded as the time when mice floated in the water and made only small movements necessary to keep their heads above the water. The total duration of immobility was measured during the last 4 min of the 6-min testing period.
Histological examination.
Lungs were removed from the mice for histopathological evaluation, and a 4% paraformaldehyde fixing solution was infused into the lungs. The lung specimens were then dehydrated and embedded in paraffin. Embedded tissue sections of 5-μm thickness were cut on a rotary microtome. Then, the specimens were placed on glass slides, deparaffinised, and stained sequentially with haematoxylin and eosin (H&E).
Inflammation in lung sections of the H&E stained specimens was measured as previously reported (Jung et al., 2016) : A subjective score ranging from 0 to 5 was evaluated on randomised, blinded sections by independent readers according to the following criteria: 0, normal; 1, very mild; 2, mild; 3, moderate; 4, marked; 5, severe inflammation.
BALF collection and inflammatory cell evaluation.
Mice were euthanized after the behavioural experiments. The lung and brain were removed en bloc, and the lung was lavaged and pooled with 1 mL of ice-cold phosphate-buffered saline (PBS) three times, resulting in 2 ± 0.2 mL of BALF. Then, the BALF was centrifuged at 300g for 10 min at 4 °C, and the supernatants were stored at -80 °C for further analyses. To analyze the inflammatory cell profiles, the BALF cells were resuspended in 1 mL of PBS. Then, BALF cells were adhered to glass slides using cytospin with Diff-Quick staining (Life Technologies, Auckland, New Zealand) to count the differential cells (neutrophils, macrophages, and lymphocytes). The results were expressed as the cell number ×10 4 .
Enzyme-linked immunosorbent assay analysis.
To analyze the proinflammatory cytokines in lung and brain, the concentrations of chemokine MCP-1; proinflammatory cytokines of IL-1β, IL-6, IL-1β, and TNF-α in the BALF; and the levels of mediators IL-1β, IL-6, IL-18, and TNF-α in the brain were determined using enzyme-linked immunosorbent assay (ELISA) kits (Nanjing Jiancheng Biotech. Co., Ltd., Nanjing, China), according to the manufacturer's instructions. The optical density was measured at 450 nm using a microplate reader (Thermos Scientific, Rockford, IL, USA), and the results of the samples were expressed as picograms per milligram protein. The level of serum corticosterone (CORT) was also determined by ELISA kit (Nanjing Jiancheng Biotech. Co., Ltd., Nanjing, China) according to the manufacturer's instructions.
Subcellular fractionation.
Nuclear and cytosol fractions were prepared using isolation kits (Beyotime Institute of Biotechnology, Shanghai, China), according to the manufacturer's instructions. For nuclear and cytoplasmic extraction, hippocampus tissues were swiftly rinsed with ice-cold PBS then spun down and vortexed according to the manufacturer's instructions. After the collection of supernatant (cytosolic fraction), the pellet fraction was then suspended and vortexed. At last, the tube was centrifuged, and the supernatants were collected as nuclear extract.
Western blot analysis.
The hippocampus samples were chopped into pieces and homogenised in an ice-cold RIPA buffer (0.1% phenylmethylsulfonyl fluoride). The solution was centrifugated, and the protein concentration of the supernatant was determined by the bicinchoninic acid assay kit (Beyotime Institute of Biotechnology Co., Ltd, Nanjing, China). Samples were loaded by a sodium dodecyl sulphate polyacrylamide gel electrophoresis, and the resolved protein was transferred onto polyvinylidene fluoride (PVDF) membranes. After blocking with 5% skim milk, the PVDF membranes were incubated with separate primary antibodies, anti-GR (BS6617, 1:500),
anti-phospho-GR Ser211 (BS4459, 1:500), anti-phospho-GR Ser226 ( 
Immunohistochemistry.
The expressions of NLRP3 and GR in the hippocampus were further examined by immunohistochemistry staining. In brief, the paraffin-embedded sections of the hippocampus were deparaffinised with xylene and rehydrated with graded ethanol.
The specimen was then incubated in 3 % hydrogen peroxide and blocked with 3 % BSA for 2 h at room temperature. The corresponding primary antibodies, anti-NLRP3
(1:100, Abcam, Cambridge, UK) and anti-GR (1:50, Bioworld Technology, MN, USA), were incubated at 4 °C overnight. After washing with PBS, the specimens were incubated with secondary antibody for 1 h. The reaction was visualised with diaminobenzidine. Images were captured with a microscope and analysed with Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis.
All data were presented as the means ± standard error of mean (SEM). Statistical evaluations of the differences among the groups were analysed by one-way analysis of variance (ANOVA) with repeated measures on body weight and SP consumption and one-way ANOVA without repeated measures followed by the post hoc Tukey test for multiple comparisons. The probability level of p < 0.05 was considered to be significant in the analyses. All statistical procedures were carried out using SPSS 21.0 (SPSS Inc., Chicago, IL, USA). There were no significant differences in the body weight of the mice in each group at the beginning of the study (Fig. 1E ). Over the 12-week experiment, repeated ANOVA showed no significant effects of week and or of week × treatment interaction, with treatment as a between factor and week as a within factor. However, a significant effect of treatment, F(1, 45) = 49.018, p < 0.001, was indicated for body weight. In addition, one-way ANOVA showed that the VEH group gained more weight than the CS group beginning with the fifth week (p < 0.01) and sustained over the following weeks (week 6: p < 0.01; week 7: p < 0.01; week 8: p < 0.05; week 9: p < 0.01; week 10: p < 0.01; week 11: p < 0.01; week 12: p < 0.01).
Results
CS exposure induced depressive-like behaviours in mice
As shown in Fig. 1B , the 12-week CS procedure caused anhedonia behaviour (measured as a reduction in sucrose solution intake as compared with the VEH group, p < 0.01). A significant decrease in body weight was also observed beginning with the fifth week as compared with the VEH group (Fig. 1E ). After the 4-week FLU treatment, the effects of the CS procedure on mice anhedonia behaviour were significantly ameliorated beginning with the 13th week, as shown by the fact that among CS-exposed mice, those treated with FLU responded with a higher sucrose intake and body weight at the 14th week (Fig. 1C , p < 0.05; Fig. 1F , p < 0.05) and 16th week (Fig. 1D , p < 0.05; Fig. 1G , p < 0.05). Among the non-CS-treated mice, the FLU treatment had no obviously effects on sucrose intake or body weight.
CS-induced depression-related behaviours were reversed by chronic FLU treatment
The effect of FLU on locomotor activity was shown in the open field test ( Fig.   2A ). Among the VEH mice, CS-exposed mice responded with a significantly fewer number of squares crossed and rearing ( Fig. 2A , p < 0.01, p < 0.01). Among CS-exposed mice, those treated with FLU significantly increased number of grooming and rearing ( Fig. 2A , p < 0.01, p < 0.01). In terms of grooming, among the VEH mice, no significant differences were observed between the non-CS-exposed and CS-exposed groups. For the TST and FST, among the VEH mice, CS-exposed mice responded with an increase in duration of immobility (Fig. 2B , p < 0.05; Fig. 2C , p < 0.001). Among CS-exposed mice, those treated with FLU responded with a significant decrease in immobile time in both TST and FST (Fig. 2B , p < 0.05; Fig. 2C , p < 0.05).
The Morris water maze was applied to evaluate the effect of CS exposure on cognitive functions in mice. Representative tracking in the Morris water maze test in the probe trial of the indicated groups is shown in Fig. 2D . After 16 weeks of CS exposure, among the VEH mice, CS-exposed mice responded with significantly increased escape latency after 5-day training (Fig. 2E , p < 0.01). On the test day, among the VEH mice, CS-exposed mice responded with a lesser platform crossing frequency and time in the target zone and a higher swimming distance ( Fig. 2F -H: F, p < 0.001; G, p < 0.001; H, p < 0.001). Among CS-exposed mice, those treated with FLU responded with improved learning and memory performance, shown as shorter escape latency, higher platform crossing frequency, longer time in the target zone, and decreased swimming distance ( Fig. 2E -H: E, p < 0.05; F, p < 0.01; G, p < 0.001; H, p < 0.05). These results showed that among CS-exposed mice, those treated with FLU prevented cognitive impairment, while among non-CS-exposed mice, FLU treatment had no obvious effects on depression-related behaviours.
CS-induced increase of inflammatory cell infiltration in the lung tissue and elevation of inflammatory cells and cytokines in the BALF were reversed by chronic FLU treatment
The lung tissues were stained with H&E to analyse the histomorphological changes challenged by CS (Fig. 3A, B) . Among VEH mice, CS-exposed mice responded with an elevation in the quantity of infiltration of inflammatory cells in both the bronchial and peribronchial layers. In contrast, among CS-exposed mice, those treated with FLU responded with a lower degree of inflammation in lung tissues.
Of note, among non-CS mice, those treated with FLU also responded with an increase in the infiltration of inflammatory cells in lung tissues, suggesting chronic FLU treatment also caused lung inflammatory injuries.
As seen from Fig. 3C , among VEH mice, CS-exposed mice responded with a significant increase in the number of inflammatory cells in lung, including neutrophils, macrophages, and lymphocytes (Fig. 3C , p < 0.001, p < 0.05, p < 0.001). In contrast, among CS-exposed mice, those treated with FLU responded with a remarkable reduction in neutrophils and lymphocytes in lung (Fig. 3C , p < 0.001, p < 0.01). It is worth noting that among non-CS mice, those treated with FLU also responded with an increase in the number of neutrophils and lymphocytes (Fig. 3C , p < 0.001, p < 0.05).
To further characterize the anti-inflammatory effects of the FLU treatment, the levels of proinflammatory cytokines in the BALF were determined by ELISA kits. As Also, among the non-CS-exposed mice, those treated with FLU responded with remarkable changes in MCP-1, IL-1β, IL-6, and TNF-α (Fig. 3D -G: D, p < 0.05; E, p < 0.05; F, p < 0.05; G, p < 0.05). Thus, chronic FLU treatment had a risk of triggering lung inflammation, whereas FLU treatment in COPD might improve inflammatory injuries.
CS-induced secretion of proinflammatory cytokines in hippocampus was attenuated by chronic FLU treatment
To investigate the effects of CS on neuroinflammation, as well as the action of FLU treatment on the proinflammatory cytokine responses in the brain, levels of hippocampal IL-1β, IL-6, TNF-α, and IL-18 were determined. After CS exposure, as shown in Fig. 4A -D, among the VEH groups, CS-exposed mice responded with significantly higher levels of hippocampal proinflammatory cytokines ( To examine the effects of CS exposure on HPA axis dysfunction, blood was collected and levels of serum CORT were also determined. As shown in Fig. 4E , among VEH groups, the CS-exposed mice responded with a 1.5-fold elevation in serum CORT level (Fig. 4E , p < 0.01). However, among CS-exposed mice, those treated with FLU reversed this elevation (Fig. 4E , p < 0.05).
CS-induced activation of the NLRP3 inflammasome in the hippocampus of mice was reversed by chronic FLU treatment
Here, we analysed the expression of hippocampal NLRP3 inflammasome components in a CS-exposed mice model of COPD with comorbid depression.
Importantly, among VEH mice, CS-exposed mice responded with a significant increase in hippocampal NLRP3 and its adaptor ASC protein levels ( Fig. 5A-C : B, p < 0.01; C, p < 0.05). Furthermore, among VEH groups, CS-exposed mice responded with a significant activation of caspase-1 (Fig. 5E , cleaved caspase-1 P10, p < 0.01) in the hippocampus, without changes in caspase-1 P45 protein levels (Fig. 5D ). Among CS-exposed mice, those treated with FLU responded with a remarkably lower level of NLRP3 inflammasome activation and caspase-1 cleavage (Fig. 5B , p < 0.05; Fig. 5E , p < 0.05). The expression of NLRP3 in the hippocampus was further examined in immunohistochemistry staining, and among VEH mice, CS-exposed mice responded with a higher level of NLRP3 both in the DG and CA1 region ( Fig. 5F G: p < 0.001; p < 0.001). Among CS-exposed mice, those treated with FLU responded with a lower level of NLRP3 inflammasome both in the DG and CA1 region ( Fig. 5F -G: p < 0.05; p < 0.05). These results demonstrated that hippocampal NLRP3 inflammasome components were activated in this animal model, which is consistent with the maturation of IL-1β and IL-18 in the hippocampus, whereas chronic administration of FLU inhibited the activation among CS-exposed mice.
CS-induced NF-κB pathway activation in the hippocampus of mice was reversed by chronic FLU treatment
To explore whether the NF-κB pathway was involved in CS-induced cytokine alterations, we analysed the levels of p-NF-κB, p-IκBα, NF-κB, and IκBα in the hippocampus. Among the VEH groups, CS-exposed mice responded with upregulated p-NF-κB and p-IκBα levels in the hippocampus of mice ( 
Effects of FLU on GR levels and GR nucleus translocation in the CS-induced model of COPD with comorbid depression.
Next, we analysed the expression of hippocampal GR signalling in mice with CS-induced COPD with comorbid depression. The GR plays an important role in depression and is involved in the effect of anti-COPD drugs on inflammation. To demonstrate whether the hippocampal GR was changed by chronic CS exposure, we first analysed the expression of total GR protein in the hippocampus. As shown in Fig.   7A , among VEH groups, mice exposed to CS for 16 weeks responded with a significant decrease in the total GR protein level (p < 0.05), and among CS-exposed mice, those treated with FLU responded with a higher level of GR protein level (p < 0.05). The expression of GR in the hippocampus was further examined in immunohistochemistry staining, and the results showed that among the VEH groups, the CS-exposed mice responded with a lower level of GR in both the DG and CA1 region ( Fig. 7B -C: p < 0.01, p < 0.01). Next, we analysed the levels of GR protein in the cytosolic and nucleus compartments. As observed in Fig. 7D and E, among VEH groups, chronic CS-exposed mice responded with a significant decrease in the GR protein level in the cytosol, without changes in GR levels in the nucleus. Thus, among the VEH groups, CS-exposed mice responded with a higher ratio of nucleus/cytosol, indicating CS changed the GR nuclear/cytosolic distribution in the hippocampus.
Interestingly, among non-CS-exposed mice, those treated with FLU also responded with a slight increase in the ratio of nuclear/cytosolic of GR. To provide further insights into the mechanism of GR nucleus translocation, we then investigated the phosphorylation status of the critical serine residues, Ser211 and Ser226 of GR, in the hippocampus. Among the VEH groups, chronic CS-exposed mice responded with increased levels of Ser211/GR and Ser226/GR in the hippocampus, while among CS-exposed mice, those treated with FLU responded with a lower level of these ratios 
Discussion
In the past two decades, there has been increasing recognition that patients suffering from COPD with comorbidities may die prematurely as compared with those without comorbidities (Yohannes and Alexopoulos, 2014) . Of these comorbidities, depression is a substantial burden for patients and their families, because the feeling of worthlessness and psychomotor retardation impair COPD patients' participation in treatment and rehabilitation. Moreover, they tend to show suicidal ideation. Notably, by suffering from impaired quality of life and detrimental treatment refusal, COPD patients who smoke are more likely to be depressed (Matte et al., 2016) . In fact, smoking tobacco is the most important risk factor for COPD patients (Garvey, 2016) . As a consequence, COPD patients who suffer from comorbid depression often continue smoking, which increases their persistent depressive and pulmonary symptoms and signs and decreases their social interactions, leading to a higher possibility of disability and mortality and poorer quality of life.
Although clinic-based studies have revealed close relationships among smoking, COPD, and depression, the underlying molecular mechanism of this phenomenon remains unclear. An appropriate animal model is essential to the research of the complex pathogenesis of these disorders. Here, in this experimental paradigm, we used chronic CS exposure to induce the animal model of COPD, and sucrose intake was recorded every 2 weeks during the 16-week CS procedure to monitor the anhedonia-like behaviour, which was defined as a core symptom of depression in depressive rodent models. Data from body weight, sucrose solution intake, open field test, TST, FST, and Morris water maze illustrated that cigarette smoking induced the animal model of COPD with comorbid depression, and chronic FLU treatment improved depression-related behaviours under this mouse model. These findings partly explained the clinical survey in which COPD patients who smoked were more likely to be depressed (Wagena et al., 2005) . The successful establishment of the animal model inspired us to further explore the potential mechanism underlying the cross talk between lung and brain.
Next, we carefully examined the pathologic and biochemical changes in both lung and brain tissues. In lung, CS-exposed mice showed severe infiltration of inflammatory cells in the bronchial and peribronchial layers, enlarged airspaces in lung tissues, increased numbers of inflammatory cells (macrophages, neutrophils, and lymphocytes), and raised concentrations of proinflammatory cytokines in the BALF, which are typical pathologic alterations in the COPD animal model. FLU administration in the CS group showed a weakened degree of lung inflammation, which suggested FLU treatment was beneficial to COPD-induced lung injuries. Of note, FLU administration in the non-CS group also showed increased infiltration of lung inflammation. These results indicate that chronic FLU administration might cause bidirectional effects on the lung tissue, which exhibited proinflammatory effects in physiological states and anti-inflammation in pathological states. These could be of clinical significance. FLU is the most commonly prescribed antidepressant with high efficacy and acceptability, even for children and adolescents (Cipriani et al.) . Our results showed that FLU treatment had the potential to improve depressive states as well as relieve lung inflammation for COPD-induced depression comorbidity, although we cannot ignore that lung inflammatory injuries might be a side effect of long-term FLU administration. Thus, FLU is probably the best option to consider for COPD patients with comorbid depression whenever a pharmacological treatment is indicated.
In our present research, CS exposure caused activated brain inflammatory responses, which might be responsible for the observed cognitive impairment.
Elevated levels of proinflammatory cytokines IL-1β, IL-18, IL-6, and TNF-α were observed in CS-exposed mice, suggesting that chronic CS exposure not only induced peripheral inflammation but also triggered CNS inflammation. FLU treatment inhibited the production of cytokines in the hippocampus of CS-exposed mice, which was consistent with recent recognition that FLU, a selective serotonin reuptake inhibitor, had potential anti-inflammatory activity, which was partially responsible for its antidepressant action (Du et al., 2016) . Our data showed that cigarette smoking triggered both peripheral inflammation and CNS inflammation, although there were controversial results of inflammatory levels in the periphery and cerebrospinal fluid (CSF) of depressed patients and animals (Martinez et al., 2012; Kagaya et al., 2001; Farooq et al., 2012) . For instance, a previous study reported that IL-1β levels in serum and CSF were unchanged in mice after an 8-week period of unpredictable chronic mild stress (Farooq et al., 2012) . Therefore, depressive animals with activated CNS inflammation may exhibit different periphery inflammatory states, which make it hard to study the common mechanisms underlying the cross talk between lung and brain. HPA is a major part of the neuroendocrine system that controls reactions to physical or mental stresses and the synthesis of the stress hormone. Hyperactivity of the HPA axis with elevated GC levels is the pathophysiological characteristic of major depression. Treatment with GC is the most recommended therapy in patients with COPD (Garvey, 2016) . Our studies demonstrated that the CS procedure produced high levels of serum CORT in mice (analogous to human cortisol) and simultaneously caused the hyperactivity of the HPA axis, indicating the GC-GR signalling activated in this animal model. Recent studies reported that GC pretreatment sensitized inflammatory responses in the CNS, which were previously considered events of GC resistance in depression, and GC also dependently induced NLRP3 mRNA expression and mature cytokine release (Frank et al., 2014) . Thus, we supposed that CS-activated GR signalling might be a central mediator to depression development with NLRP3
inflammasome-triggered CNS inflammation. This highlighted the need to prove the possible role of GR signaling in the pathological process of inflammasome-related CNS inflammation in COPD with comorbid depression.
In the following context, we showed that total GR protein levels were decreased by chronic CS exposure, suggesting that prolonged exposure to CS impaired GR expressions. In fact, total GR expressions were down-regulated or unchanged in different animal models of depression (Shilpa et al., 2017; Ago et al., 2008; Szymańska et al., 2009 ). These results might be explained by the fact that compared with a short simulation period, long-term stimulator-induced HPA over-activation reduced the feedback inhibition of GC release and impaired GR function, which could more easily lead to GC resistance. FLU treatment in the CS group reversed this downregulation of GR expression, showing a protective role of FLU to GR. As we know, GR remains in an inactive state in the cytoplasm and executes its function only when it translocates from the cytoplasm to the nucleus when it binds to GC. Therefore, to further study the functional mechanisms of FLU, we investigated the effects of FLU on GR nucleus translocation by measuring the GR levels in both the cytosol and nucleus. Chronic CS exposure significantly decreased the GR protein levels in the cytosol, without changing the GR in the nucleus. Thus, the ratio of nucleus/cytosol was increased under the CS challenge, indicating that CS changed the GR nuclear/cytosolic distribution in the hippocampus. It is noteworthy that chronic FLU treatment also slightly increased the nuclear/cytosolic ratio of GR in the non-CS group. Thus, chronic CS exposure suppressed the cytosolic GR binding capacity and elevated the level of active nuclear GR, which might weaken the feedback inhibition of the HPA axis, thus leading to the activation of inflammasome-induced inflammatory cascade. Our findings showed that FLU treatment regulated nuclear/cytosolic GR distribution, raising the possibility that FLU exhibited negative effects on neuroinflammation by restoring normal GR function. To provide further insights into the mechanism of GR nucleus translocation, we examined the crucial phosphorylated site of GR. Like many nucleus receptors, GR is a phosphoprotein that becomes hyperphosphorylated upon binding to GC. The phosphorylation of GR at site Ser211 facilitates nucleus translocation and increases the transcriptional activities of the receptor, while conversely, phosphorylation at site Ser226 inhibits nucleus translocation and decreases GR transcriptional activities (Ismaili and Garabedian, 2004) . Our results showed that chronic CS exposure significantly increased the levels of both Ser211/GR and Ser226/GR in the hippocampus. The ratio of pGR-S211/pGR-S226 was lower in the CS group mice as compared with the VEH group, indicating that the transcriptional activity of GR was impaired under CS exposure. Thus, CS exposure triggered an inflammasome-induced inflammatory cascade. Thus, chronic CS exposure led to increased active nuclear GR, impaired cytosolic GR binding capacity, and GR transcriptional activity, which might be responsible for the activation of inflammasome-induced inflammatory cascade. FLU treatment increased the Ser211/Ser226 ratio, which further illustrated that FLU restored the balance of the GR distribution and inspired the GR transcriptional activity by modulating GR phosphorylation.
Conclusion
In conclusion, our work showed that GC resistance occurred in a CS-induced COPD model comorbid with depression. GR dysfunction orchestrated inflammasome effects on COPD-induced depression, which might be a potential linkage that facilitates the cross talk between the lung and brain. CS+VEH group compared with non-CS+VEH group: # p < 0.05, ## p < 0.01, ### p < 0.001; CS+FLU group compared with CS+VEH group: * p < 0.05, ** p < 0.01, *** p < 0.001. CS+VEH group compared with non-CS+VEH group: # p < 0.05, ## p < 0.01, ### p < 0.001; CS+FLU group compared with CS+VEH group: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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